{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T06:42:46Z","timestamp":1774334566182,"version":"3.50.1"},"reference-count":47,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,3,18]],"date-time":"2019-03-18T00:00:00Z","timestamp":1552867200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurosci."],"DOI":"10.3389\/fnins.2019.00218","type":"journal-article","created":{"date-parts":[[2019,3,18]],"date-time":"2019-03-18T00:15:53Z","timestamp":1552868153000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":35,"title":["Elevated Plasma microRNA-105-5p Level in Patients With Idiopathic Parkinson\u2019s Disease: A Potential Disease Biomarker"],"prefix":"10.3389","volume":"13","author":[{"given":"Zhaofei","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tianbai","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanhua","family":"Cui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Song","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheng","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bairong","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weidong","family":"Le","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2019,3,18]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/S0092-8674(04)00045-5","article-title":"MicroRNAs: genomics, biogenesis, mechanism, and function.","volume":"116","author":"Bartel","year":"2004","journal-title":"Cell"},{"key":"B2","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1080\/00207454.2016.1209754","article-title":"An overview of circulating cell-free microRNAs as putative biomarkers in alzheimer\u2019s and parkinson\u2019s diseases.","volume":"127","author":"Batistela","year":"2017","journal-title":"Int. J. Neurosci."},{"key":"B3","doi-asserted-by":"publisher","first-page":"23107","DOI":"10.1074\/jbc.M109.013862","article-title":"Modulation of TLR2 protein expression by a miR-105 in human oral keratinocytes.","volume":"284","author":"Benakanakere","year":"2009","journal-title":"J. Biol. Chem."},{"key":"B4","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false discovery rate: a practical and powerful approach to multiple testing.","volume":"57","author":"Benjamini","year":"1995","journal-title":"J. R. Stat. Soc. Ser. B"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0094839","article-title":"Profiles of extracellular miRNA in cerebrospinal fluid and serum from patients with alzheimer\u2019s and parkinson\u2019s diseases correlate with disease status and features of pathology.","volume":"9","author":"Burgos","year":"2014","journal-title":"PLoS One"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1186\/1479-5876-11-169","article-title":"Clear cell renal cell carcinoma associated microRNA expression signatures identified by an integrated bioinformatics analysis.","volume":"11","author":"Chen","year":"2013","journal-title":"J. Transl. Med."},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2018.00178","article-title":"Integrated analysis and identification of novel biomarkers in parkinson\u2019s disease.","volume":"10","author":"Chi","year":"2018","journal-title":"Front. Aging Neurosci."},{"key":"B8","author":"Chongsuvivatwong","year":"2012","journal-title":"Epicalc: Epidemiological Calculator"},{"key":"B9","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.gene.2012.07.058","article-title":"A miRNA signature in leukocytes from sporadic amyotrophic lateral sclerosis.","volume":"508","author":"De Felice","year":"2012","journal-title":"Gene"},{"key":"B10","doi-asserted-by":"publisher","first-page":"4259","DOI":"10.1007\/s00018-013-1352-y","article-title":"The role of inflammation in sporadic and familial parkinson\u2019s disease.","volume":"70","author":"Deleidi","year":"2013","journal-title":"Cell. Mol. Life Sci."},{"key":"B11","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.parkreldis.2015.11.014","article-title":"Identification of a panel of five serum miRNAs as a biomarker for parkinson\u2019s disease.","volume":"22","author":"Ding","year":"2016","journal-title":"Parkinson. Relat. Disord."},{"key":"B12","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1155\/2015\/625659","article-title":"Serum MicroRNA profiles serve as novel biomarkers for the diagnosis of alzheimer\u2019s disease.","volume":"2015","author":"Dong","year":"2015","journal-title":"Dis. Mark."},{"key":"B13","doi-asserted-by":"publisher","first-page":"129","DOI":"10.3109\/1354750X.2015.1118544","article-title":"A panel of four decreased serum microRNAs as a novel biomarker for early parkinson\u2019s disease.","volume":"21","author":"Dong","year":"2016","journal-title":"Biomarkers"},{"key":"B14","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1093\/nar\/30.1.207","article-title":"Gene expression omnibus: NCBI gene expression and hybridization array data repository.","volume":"30","author":"Edgar","year":"2002","journal-title":"Nucl. Acids Res."},{"key":"B15","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1007\/s10753-015-0259-1","article-title":"Anti-inflammatory activity of tanshinone IIA in LPS-stimulated RAW264. 7 macrophages via miRNAs and TLR4\u2013NF-\u03baB pathway.","volume":"39","author":"Fan","year":"2016","journal-title":"Inflammation"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0013534","article-title":"Exprtarget: an integrative approach to predicting human microRNA targets.","volume":"5","author":"Gamazon","year":"2010","journal-title":"PLoS One"},{"key":"B17","doi-asserted-by":"publisher","first-page":"2225","DOI":"10.1093\/hmg\/ddr111","article-title":"Hsa-miR-34b is a plasma-stable microRNA that is elevated in pre-manifest huntington\u2019s disease.","volume":"20","author":"Gaughwin","year":"2011","journal-title":"Hum. Mol. Genet."},{"key":"B18","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.gene.2011.03.005","article-title":"HOCTAR database: a unique resource for microRNA target prediction.","volume":"480","author":"Gennarino","year":"2011","journal-title":"Gene"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygeno.2018.05.005","article-title":"Gene co-expression network analysis for identifying genetic markers in parkinson\u2019s disease-a three-way comparative approach.","author":"George","year":"2018","journal-title":"Genomics"},{"key":"B20","article-title":"Identification of low miR-105 expression as a novel poor prognostic predictor for human glioma.","volume":"8","author":"Guan","year":"2015","journal-title":"Int. J. Clin. Exp. Med."},{"key":"B21","doi-asserted-by":"publisher","first-page":"D78","DOI":"10.1093\/nar\/gkt1266","article-title":"miRTarBase update 2014: an information resource for experimentally validated miRNA-target interactions.","volume":"42","author":"Hsu","year":"2014","journal-title":"Nucl. Acids Res."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1212\/WNL.57.8.1497","article-title":"Improved accuracy of clinical diagnosis of lewy body parkinson\u2019s disease.","volume":"57","author":"Hughes","year":"2001","journal-title":"Neurology"},{"key":"B23","doi-asserted-by":"publisher","first-page":"D98","DOI":"10.1093\/nar\/gkn714","article-title":"miR2Disease: a manually curated database for microRNA deregulation in human disease.","volume":"37","author":"Jiang","year":"2008","journal-title":"Nucl. Acids Res."},{"key":"B24","doi-asserted-by":"publisher","first-page":"321","DOI":"10.3233\/JPD-012144","article-title":"Plasma-based circulating microRNA biomarkers for parkinson\u2019s disease.","volume":"2","author":"Khoo","year":"2012","journal-title":"J. Parkin. Dis."},{"key":"B25","doi-asserted-by":"publisher","first-page":"D92","DOI":"10.1093\/nar\/gkt1248","article-title":"starBase v2. 0: decoding miRNA-ceRNA, miRNA-ncRNA and protein\u2013RNA interaction networks from large-scale CLIP-Seq data.","volume":"42","author":"Li","year":"2013","journal-title":"Nucl. Acids Res."},{"key":"B26","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1007\/s12264-017-0178-2","article-title":"Milestones of parkinson\u2019s disease research: 200 years of history and beyond.","volume":"33","author":"Li","year":"2017","journal-title":"Neurosci. Bull."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1080\/15476286.2018.1502590","article-title":"MiRNA-BD: an evidence-based bioinformatics model and software tool for microRNA biomarker discovery.","volume":"15","author":"Lin","year":"2018","journal-title":"RNA Biol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"3865","DOI":"10.1093\/nar\/gkw116","article-title":"Distribution of miRNA expression across human tissues.","volume":"44","author":"Ludwig","year":"2016","journal-title":"Nucl. Acids Res."},{"key":"B29","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1002\/cbf.3224","article-title":"Serum miR-221 serves as a biomarker for parkinson\u2019s disease.","volume":"34","author":"Ma","year":"2016","journal-title":"Cell Biochem. Funct."},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0025443","article-title":"Convergence of miRNA expression profiling, \u03b1-synuclein interacton and GWAS in parkinson\u2019s disease.","volume":"6","author":"Martins","year":"2011","journal-title":"PLoS One"},{"key":"B31","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/S1474-4422(04)00736-7","article-title":"Functional brain imaging in the differential diagnosis of parkinson\u2019s disease.","volume":"3","author":"Piccini","year":"2004","journal-title":"Lancet Neurol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1002\/mds.26424","article-title":"MDS clinical diagnostic criteria for parkinson\u2019s disease.","volume":"30","author":"Postuma","year":"2015","journal-title":"Mov. Disord."},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1038\/sj.cr.7290235","article-title":"Biomarkers of neurodegenerative disorders: how good are they?","volume":"14","author":"Rachakonda","year":"2004","journal-title":"Cell Res."},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.3390\/ijms17060904","article-title":"Neuroprotective and therapeutic strategies against parkinson\u2019s disease: recent perspectives.","volume":"17","author":"Sarkar","year":"2016","journal-title":"Int. J. Mol. Sci."},{"key":"B35","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1073\/pnas.0610204104","article-title":"Molecular markers of early parkinson\u2019s disease based on gene expression in blood.","volume":"104","author":"Scherzer","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-017-0048-x","article-title":"MicroRNA-105 is involved in TNF-\u03b1-related tumor microenvironment enhanced colorectal cancer progression.","volume":"8","author":"Shen","year":"2017","journal-title":"Cell Death Dis."},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1186\/s12920-018-0357-7","article-title":"A meta-analysis of public microarray data identifies biological regulatory networks in parkinson\u2019s disease.","volume":"11","author":"Su","year":"2018","journal-title":"BMC Med. Genomics"},{"key":"B38","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1111\/jnc.13691","article-title":"The clinical symptoms of parkinson\u2019s disease.","volume":"139","author":"Sveinbjornsdottir","year":"2016","journal-title":"J. Neurochem."},{"key":"B39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2018\/1590465","article-title":"Microarray analysis of the molecular mechanism involved in parkinson\u2019s disease.","volume":"2018","author":"Tan","year":"2018","journal-title":"Parkinson\u2019s Dis."},{"key":"B40","doi-asserted-by":"publisher","first-page":"2497","DOI":"10.4155\/bio-2016-0166","article-title":"Recent developments in circulating biomarkers in parkinson\u2019s disease: the potential use of miRNAs in a clinical setting.","volume":"8","author":"Teixeira dos Santos","year":"2016","journal-title":"Bioanalysis"},{"key":"B41","doi-asserted-by":"publisher","first-page":"D222","DOI":"10.1093\/nar\/gkr1161","article-title":"TarBase 6.0: capturing the exponential growth of miRNA targets with experimental support.","volume":"40","author":"Vergoulis","year":"2011","journal-title":"Nucl. Acids Res."},{"key":"B42","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1007\/s12264-017-0160-z","article-title":"Tiny but mighty: promising roles of MicroRNAs in the diagnosis and treatment of parkinson\u2019s disease.","volume":"33","author":"Wang","year":"2017","journal-title":"Neurosci. Bull."},{"key":"B43","doi-asserted-by":"publisher","first-page":"D105","DOI":"10.1093\/nar\/gkn851","article-title":"miRecords: an integrated resource for microRNA\u2013target interactions.","volume":"37","author":"Xiao","year":"2008","journal-title":"Nucl. Acids Res."},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2016.00298","article-title":"microRNAs: emerging targets regulating oxidative stress in the models of parkinson\u2019s disease.","volume":"10","author":"Xie","year":"2016","journal-title":"Front. Neurosci."},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1093\/molbev\/msp112","article-title":"Identification of novel homologous microRNA genes in the rhesus macaque genome.","volume":"9","author":"Yue","year":"2008","journal-title":"BMC genomics"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1177\/1010428317705766","article-title":"MicroRNA-105 inhibits human glioma cell malignancy by directly targeting SUZ12.","volume":"39","author":"Zhang","year":"2017","journal-title":"Tumor Biol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.molcel.2010.06.010","article-title":"Secreted monocytic miR-150 enhances targeted endothelial cell migration.","volume":"39","author":"Zhang","year":"2010","journal-title":"Mol. Cell"}],"container-title":["Frontiers in Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fnins.2019.00218\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,3,18]],"date-time":"2019-03-18T00:15:55Z","timestamp":1552868155000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fnins.2019.00218\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,18]]},"references-count":47,"alternative-id":["10.3389\/fnins.2019.00218"],"URL":"https:\/\/doi.org\/10.3389\/fnins.2019.00218","relation":{},"ISSN":["1662-453X"],"issn-type":[{"value":"1662-453X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,18]]},"article-number":"218"}}